Type 2 & other diabetes

Body Mass Index and All‐Cause, Cancer, and Cardiovascular Mortality in Adults Aged 16–50 Years With and Without Type 2 Diabetes: An Analysis of Primary Care Records in England

Diabetes Obes MetabPublished Retrospective matched cohort study

Authors' conclusion

The excess risk of mortality associated with T2D was greatest at lower BMI, where absolute risk estimates were high.

Study context

Population
Adults aged 16–50 years with and without T2D, primary care records in England (Clinical Practice Research Datalink (CPRD)); median age at T2D diagnosis 44.0 yearsmatched cohort
Participants
384,787 adults
Exposure
T2D vs no T2D across body mass index (BMI)
  • T2Dn = 86,606
Outcome
All-cause, cancer and CVD mortality by BMI
Follow-up
10-year cumulative incidence
Methodological detailsmatched 1: up to 10 by year of birth, sex and general practice, CPRD linked to Hospital Episode Statistics (HES) and Office for National Statistics (ONS) mortality records, flexible parametric survival models, competing risk approaches
  • Matched 1: up to 10 by year of birth, sex and general practice
  • CPRD linked to HES and ONS mortality records
  • Flexible parametric survival models
  • Competing risk approaches

Main finding

As reported in the abstract

BMI and all-cause and cause-specific mortality

U-shaped association; nadir at BMI in T2D

29.3 kg/m²

U-shaped association; nadir at BMI without T2D

27.2 kg/m²

Observational data: associations, not effects.

Further findings

OutcomeT2DWithout T2D
10-year cumulative incidence of all-cause mortality at age 45 years and BMI 20 kg/m²17.3% (95% CI 13.9%–20.6%)4.4% (95% CI 4.0%–4.7%)

Original publication

Body Mass Index and All‐Cause, Cancer, and Cardiovascular Mortality in Adults Aged 16–50 Years With and Without Type 2 Diabetes: An Analysis of Primary Care Records in England. Diabetes Obes Metab. Published 12 May 2026. doi:10.1111/dom.70844

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.